Well it depends right! CARE is also a well recognized firm so I would not be overly concerned. Yes, i think it might have been cheaper to appoint CARE than CRISIL. So i think the decision is more cost related than anything else. The company has active conversations with institutional investors and DII are invested which is usually a good sign to judge any corporate CG issues.
Subscribe To Our Free Newsletter |